Ammonia solution dilute
Requires a prescription from a doctor or prescriber
Ammonia is a naturally-occurring compound with a chemical formula NH3 and structure of trigonal pyramidal geometry.
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Suspected adverse reactions reported for Ammonia
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(4)
Pegzilarginase for treating arginase-1 deficiency in people 2 years and over (HST35)
Rifaximin for preventing episodes of overt hepatic encephalopathy (TA337)
Cirrhosis in over 16s: assessment and management (NG50)
AmnioSense for unexplained vaginal wetness in pregnancy (MIB198)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 30 studies.
Reviews & meta-analyses: 5 · 2019–2023
Showing all 30 studies, sorted by most relevant.
Yuecheng Xiong, Yunhao Wang, Jingwen Zhou, et al.
Advanced Materials, 2023
Wai Siong Chai, Yulei Bao, J. Pengfei, et al.
Renewable & Sustainable Energy Reviews, 2021
A. Valera-Medina, F. Amer-Hatem, A. Azad, et al.
Energy & Fuels, 2021
S. Ghavam, M. Vahdati, I. Wilson, et al.
2021
Due to the important role of ammonia as a fertilizer in the agricultural industry and its promising prospects as an energy carrier, many studies have recently attempted to find the most environmentally benign, energy efficient, and economically viable production process for ammonia synthesis. The most commonly utilized ammonia production method is the Haber-Bosch process. The downside to this technology is the high greenhouse gas emissions, surpassing 2.16 kgCO 2 -eq/kg NH 3 and high amounts of energy usage of over 30 GJ/tonne NH3 mainly due to the strict operational conditions at high temperature and pressure. The most widely adopted technology for sustainable hydrogen production used for ammonia synthesis is water electrolysis coupled with renewable technologies such as wind and solar. In general, a water electrolyzer requires a continuous supply of pretreated water with high purity levels for its operation. Moreover, for production of 1 tonne of hydrogen, 9 tonnes of water is required. Based on this data, for the production of the same amount of ammonia through water electrolysis, 233.6 million tonnes/yr of water is required. In this paper, a critical review of different sustainable hydrogen production processes and emerging technologies for sustainable ammonia synthesis along with a comparative life cycle assessment of various ammonia production methods has been carried out. We find that through the review of each of the studied technologies, either large amounts of GHG emissions are produced or high volumes of pretreated water is required or a combination of both these factors occur.
Abstract licence: CC BY
Shuhe Han, Hongjiao Li, Tieliang Li, et al.
Nature Catalysis, 2023
Xianbiao Fu, Jakob B. Pedersen, Yuanyuan Zhou, et al.
Science, 2023
Panpan Li, Ran Li, Yuanting Liu, et al.
Journal of the American Chemical Society, 2023
Di Liu, Lulu Qiao, Shuyang Peng, et al.
Advanced Functional Materials, 2023
Rong Zhang, Chuan Li, Huilin Cui, et al.
Nature Communications, 2023
Abstract Most current research is devoted to electrochemical nitrate reduction reaction for ammonia synthesis under alkaline/neutral media while the investigation of nitrate reduction under acidic conditions is rarely reported. In this work, we demonstrate the potential of TiO 2 nanosheet with intrinsically poor hydrogen-evolution activity for selective and rapid nitrate reduction to ammonia under acidic conditions. Hybridized with iron phthalocyanine, the resulting catalyst displays remarkably improved efficiency toward ammonia formation owing to the enhanced nitrate adsorption, suppressed hydrogen evolution and lowered energy barrier for the rate-determining step. Then, an alkaline-acid hybrid Zn-nitrate battery was developed with high open-circuit voltage of 1.99 V and power density of 91.4 mW cm –2 . Further, the environmental sulfur recovery can be powered by above hybrid battery and the hydrazine-nitrate fuel cell can be developed for simultaneously hydrazine/nitrate conversion and electricity generation. This work demonstrates the attractive potential of acidic nitrate reduction for ammonia electrosynthesis and broadens the field of energy conversion.
Abstract licence: CC BY
Huihuang Fang, Simson Wu, Tuğçe Ayvalı, et al.
Nature Communications, 2023
Abstract Ammonia is regarded as an energy vector for hydrogen storage, transport and utilization, which links to usage of renewable energies. However, efficient catalysts for ammonia decomposition and their underlying mechanism yet remain obscure. Here we report that atomically-dispersed Ru atoms on MgO support on its polar (111) facets {denoted as MgO(111)} show the highest rate of ammonia decomposition, as far as we are aware, than all catalysts reported in literature due to the strong metal-support interaction and efficient surface coupling reaction. We have carefully investigated the loading effect of Ru from atomic form to cluster/nanoparticle on MgO(111). Progressive increase of surface Ru concentration, correlated with increase in specific activity per metal site, clearly indicates synergistic metal sites in close proximity, akin to those bimetallic N 2 complexes in solution are required for the stepwise dehydrogenation of ammonia to N 2 /H 2 , as also supported by DFT modelling. Whereas, beyond surface doping, the specific activity drops substantially upon the formation of Ru cluster/nanoparticle, which challenges the classical view of allegorically higher activity of coordinated Ru atoms in cluster form (B 5 sites) than isolated sites.
Abstract licence: CC BY
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
Not available
Mechanism
Renal excretion and metabolism of ammonia is critical in regulation of acid-base…
Food interactions
None known
Human targets
None mapped
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Absorption
10-27 minutes
Half-life
3 seconds
[L2033]
Metabolism
Elimination
[L2033]
Pharmacokinetic data: DrugBank · CC BY-NC 4.0
- (when radiolabelled) Indicated for diagnostic PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease [FDA Label].
While mammals has various mechanisms to detoxify and excrete ammonia from the body, death has been reported after an exposure to 10,000 ppm for an unknown duration. Bradycardia was seen at 2,500 ppm, and hypertension and cardiac arrhythmias leading to cardiovascular collapse followed acute exposures to concentrations exceeding 5,000 ppm .
[L2033]
How the body processes this drug — absorption, distribution, metabolism, and elimination
[L2033]
In healthy male subjects under exposure to 500 ppm ammonia for 10-27 minutes, about 70-80% of total inspired ammonia was expired .
[L2033]
In extrahepatic tissues such as the intestine, ammonia is incorporated into nontoxic glutamine and released into blood, where it is transported to the liver for ureagenesis .
[L2033]
[L2033]
[A32385]
In case of hepatic dysfunction or impairment, detoxification capacity decreases and may cause severe pathologies from hyperammonemia, such as hepatic encephalopathy .
[L2033]
[L2033]
Enzymes involved in drug metabolism — important for understanding drug interactions
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Ammonia
Additional database identifiers
Drugs Product Database (DPD)
10102
HUGO Gene Nomenclature Committee (HGNC)
HGNC:29570
GenAtlas
GLS2
GeneCards
GLS2
GenBank Gene Database
AF110330
GenBank Protein Database
6650606
UniProt Accession
GLSL_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:4341
GenAtlas
GLUL
GeneCards
GLUL
GenBank Gene Database
Y00387
GenBank Protein Database
31833
UniProt Accession
GLNA_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:2323
GeneCards
CPS1
UniProt Accession
CPSM_HUMAN
DrugBank citations
If you use DrugBank data in your research, please cite the following publications:
Show earlier publications
Structured knowledge from the free knowledge base
Linked open data from Wikidata (Q4087), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication.